Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Covington
Fish and Richardson
Johnson and Johnson
Accenture
Farmers Insurance
Express Scripts
US Army
Colorcon
Mallinckrodt

Generated: February 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 060733

« Back to Dashboard

NDA 060733 describes BACITRACIN, which is a drug marketed by Akorn, Fresenius Kabi Usa, Mylan Asi, Pfizer, Pharmacia And Upjohn, Xellia Pharms Aps, Lilly, Perrigo Co Tennessee, Pharmaderm, Pharmafair, Combe, Naska, Apothekernes, Paddock Llc, Bausch And Lomb, and Altana, and is included in twenty-three NDAs. It is available from nine suppliers. Additional details are available on the BACITRACIN profile page.

The generic ingredient in BACITRACIN is bacitracin; hydrocortisone acetate; neomycin sulfate; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the bacitracin; hydrocortisone acetate; neomycin sulfate; polymyxin b sulfate profile page.
Summary for 060733
Tradename:BACITRACIN
Applicant:Pharmacia And Upjohn
Ingredient:bacitracin
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 060733
Medical Subject Heading (MeSH) Categories for 060733
Suppliers and Packaging for NDA: 060733
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BACITRACIN bacitracin INJECTABLE;INJECTION 060733 ANDA Pharmacia and Upjohn Company LLC 0009-0233 N 0009-0233-01
BACITRACIN bacitracin INJECTABLE;INJECTION 060733 ANDA Pharmacia and Upjohn Company LLC 0009-0233 N 0009-0233-03

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength10,000 UNITS/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength50,000 UNITS/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Express Scripts
US Department of Justice
Chubb
AstraZeneca
Merck
UBS
Covington
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot